Edition:
India

People: Pacira Biosciences Inc (PCRX.OQ)

PCRX.OQ on NASDAQ Stock Exchange Global Select Market

36.54USD
23 Aug 2019
Change (% chg)

$-1.40 (-3.69%)
Prev Close
$37.94
Open
$37.93
Day's High
$38.08
Day's Low
$36.42
Volume
192,291
Avg. Vol
176,470
52-wk High
$54.92
52-wk Low
$35.09

Reinhardt, Max 

Mr. Max Reinhardt is President of the Company. He served as Vice President of Marketing for DePuy Synthes, part of the Johnson & Johnson Medical Devices Companies (“Johnson & Johnson”), since March 2016. Prior to serving as Vice President of Marketing at DePuy Synthes Sales, Inc., Mr. Reinhardt was Director of Sales and Marketing for DePuy Spine and Vice President of US Sales for DePuy Spine. In 2011, he was named Vice President, Worldwide Marketing of DePuy Synthes, a position in which he played a key role in the acquisition and integration of Synthes Spine. In 2012, he was named Worldwide President, DePuy Synthes Spine, and led the spine business through the first two years of integration. Prior to Johnson & Johnson, Mr. Reinhardt served in sales leadership roles at both Olympus KeyMed and STERIS Corporation in the United Kingdom.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --